|
|
|
| home > white papers > eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials - Clinical Ink |
|
|
 WHITE PAPERS |
|
|
Clinical Ink
|
|
eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials
|
|
More sponsors and CROs are looking for new ways to better leverage investigative site relationships to improve clinical trial performance. To this end, some clinical organizations have adopted electronic source (eSource) to help improve study quality and efficiency - for both sponsor and site. Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. As SureSource adoption increased, study teams began to see an improvement in data quality, operational efficiency and ease of use compared to traditional methods (paper and EDC). A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Biognosys Announces the Launch of its Next-Generation Plasma Biomarker Discovery Solution
October 5th, 2021 – SCHLIEREN, (Zurich, Switzerland). Biognosys, a
leader in next-generation proteomics solutions for drug discovery and
development, today announces the upcoming launch of its next-generation
plasma biomarker discovery solution.
More info >> |
|
 |
White Papers |
 |
|
Pharmaceutical Companies: Outsourcing Combination Product Manufacturing
Phillips-Medisize
Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
More info >> |
|
|
|
